一次性內視鏡市場機會、成長動力、產業趨勢分析及2025-2034年預測

2024 年全球一次性內視鏡市場規模達 19 億美元，預計到 2034 年將以 16.4% 的複合年成長率成長，達到 85 億美元。這一顯著成長主要得益於人們對微創手術的日益青睞，以及癌症和胃腸道疾病等慢性疾病的日益普及。發炎性腸道疾病、消化性潰瘍、大腸直腸癌和食道併發症等疾病的發生率穩定上升，這主要歸因於不良的飲食習慣、久坐的生活方式和人口老化，這持續推動了對早期診斷工具的需求。由於這些疾病通常需要頻繁檢查，一次性內視鏡已成為更安全的選擇，可以降低醫院內感染的風險以及可重複使用內視鏡可能發生的交叉污染。

專為一次性使用的內視鏡設計，無論是軟性內視鏡或剛性內視鏡，均具備診斷與治療功能。其主要優點之一是無需複雜的滅菌過程，非常適合在床邊或急救環境中使用。整合CMOS感測器技術的經濟高效的設計提高了成像清晰度和手術過程中的即時可視性，推動了其在各種醫療環境中，尤其是在資源有限的環境中的進一步應用。

預計支氣管鏡市場將強勁擴張，複合年成長率達17%，到2034年將達31億美元。一次性支氣管鏡日益受到青睞，是因為它們能夠最大限度地降低重症監護室（ICU）等高風險環境中的感染風險。這些設備因其即用型功能而備受青睞，尤其是在重症監護和創傷治療場景中，這些場景需要快速干涉，而傳統內視鏡的重複處理又不切實際。

2024年，醫院佔了最大的市場佔有率，佔63.9%。由於手術量大且基礎設施完善，醫院逐漸轉向一次性內視鏡解決方案，以提高安全性和營運效率。傳統的可重複使用內視鏡，尤其是在外科手術科室，有較高的感染傳播風險。相較之下，一次性內視鏡的感染風險較低，因此在醫院內感染（HAI）對病患健康和機構成本構成重大風險的關鍵科室中，一次性內視鏡成為首選。

美國一次性內視鏡市場在2024年達到8.959億美元，預計到2034年將以15.3%的複合年成長率成長。美國領先的地位得益於其完善的醫療保健體系、較高的手術量以及對創新技術的早期應用。對感染控制措施的日益重視進一步刺激了對一次性解決方案的需求。優惠的報銷結構、FDA的監管支持以及國內企業的大量研發投入，也為快速的產品開發和市場擴張創造了有利環境。

引領一次性內視鏡產業的主要參與者包括奧林巴斯、HugeMed、波士頓科學、RICHARD WOLF、Flexicare、Ambu、Karl Storz、CooperSurgical、Parburch MEDICAL 和 Hoya Corporation。該市場的領先公司正專注於新產品發布、策略合作和技術創新，以加強其影響力。許多公司正在投資先進的影像技術和人體工學，以提高可用性和程序效率。此外，公司也正在進行併購，以擴大產品組合併進入尚未開發的區域市場。一些參與者強調可擴展的生產能力和經濟實惠的設計，以滿足新興經濟體日益成長的需求。同時，與醫院和臨床研究機構的合作有助於驗證產品性能並推動其在醫療環境中的更廣泛應用。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 胃腸道疾病、癌症和其他慢性疾病發生率上升
    • 微創手術的需求不斷增加
    • 一次內視鏡的技術進步
    • 更加重視污染和感染控制
  • 產業陷阱與挑戰
    • 缺乏熟練的醫師和內視鏡醫師
  • 市場機會
    • 監理推動感染控制
• 成長潛力分析
• 監管格局
  • 北美洲
  • 歐洲
  • 排
• 技術和創新格局
  • 當前的技術趨勢
  • 新興技術
• 定價分析
• 報銷場景
• 差距分析
• 波特的分析
• 管道分析
• PESTEL分析
• 差距分析

第4章：競爭格局

• 介紹
• 公司矩陣分析
• 公司市佔率分析
  • 按地區
    • 北美洲
    • 歐洲
    • 排
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 關鍵進展
  • 併購
  • 夥伴關係和合作
  • 新產品發布
  • 擴張計劃

第5章：市場估計與預測：依產品類型，2021 - 2034 年

• 主要趨勢
• 支氣管鏡
• 膀胱鏡
• 十二指腸鏡
• 子宮腔鏡
• 喉鏡
• 輸尿管鏡
• 其他產品類型

第6章：市場估計與預測：依最終用途，2021 - 2034 年

• 主要趨勢
• 醫院
• 門診手術中心
• 其他最終用途

第7章：市場估計與預測：按地區，2021 - 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 排

第8章：公司簡介

• Ambu
• Boston Scientific
• CooperSurgical
• Flexicare
• Hoya Corporation
• HugeMed
• Karl Storz
• OLYMPUS
• Parburch MEDICAL
• RICHARD WOLF

The Global Disposable Endoscopes Market was valued at USD 1.9 billion in 2024 and is estimated to grow at a CAGR of 16.4% to reach USD 8.5 billion by 2034. This notable growth is largely driven by the increasing preference for minimally invasive procedures and the growing prevalence of chronic diseases such as cancer and gastrointestinal disorders. A steady rise in conditions like inflammatory bowel disease, peptic ulcers, colorectal cancer, and esophageal complications-largely attributed to poor dietary habits, sedentary lifestyles, and aging populations-continues to boost the need for early diagnostic tools. As these conditions often demand frequent examinations, disposable endoscopes have emerged as a safer option, reducing the risk of hospital-acquired infections and cross-contamination that may occur with reusable scopes.

Designed for single-use, disposable endoscopes-whether flexible or rigid-offer both diagnostic and therapeutic capabilities. One of their major advantages is that they eliminate the need for complex sterilization processes, making them ideal for use in point-of-care or emergency settings. The introduction of cost-effective designs integrated with CMOS sensor technology has improved imaging clarity and real-time visibility during procedures, driving further adoption in various healthcare environments, especially in resource-limited settings.

The bronchoscopes segment is forecasted to witness strong expansion, growing at a CAGR of 17% to reach USD 3.1 billion by 2034. The rising inclination toward single-use bronchoscopes stems from their ability to minimize infection risks in high-stakes environments like ICUs. These devices are now preferred for their ready-to-use functionality, especially in critical care and trauma scenarios where rapid intervention is necessary and time-consuming reprocessing of traditional scopes is impractical.

In 2024, hospitals accounted for the largest share of the market, generating 63.9%. With a high procedural load and established infrastructure, hospitals are increasingly transitioning to disposable endoscopic solutions to enhance safety and operational efficiency. Traditional reusable scopes, especially in surgical units, present a greater risk of infection transmission. In contrast, disposable scopes offer a lower infection profile, making them a preferred choice in critical departments where HAIs pose a significant risk to patient health and institutional costs.

United States Disposable Endoscopes Market generated USD 895.9 million in 2024 and is set to grow at a CAGR of 15.3% through 2034. The country's leading position is supported by a well-established healthcare system, high surgical volumes, and early adoption of innovative technologies. Growing emphasis on infection control practices has further fueled demand for disposable solutions. Favorable reimbursement structures, regulatory support from the FDA, and substantial R&D investments from domestic companies have also created an environment conducive to rapid product development and market expansion.

Key players leading the Disposable Endoscopes Industry include Olympus, HugeMed, Boston Scientific, RICHARD WOLF, Flexicare, Ambu, Karl Storz, CooperSurgical, Parburch MEDICAL, and Hoya Corporation. Leading companies in this market are focusing on new product launches, strategic collaborations, and technological innovation to strengthen their presence. Many are investing in advanced imaging technologies and ergonomics to enhance usability and procedural efficiency. Mergers and acquisitions are also being pursued to expand product portfolios and gain access to untapped regional markets. Some players are emphasizing scalable production capabilities and affordable designs to cater to growing demand from emerging economies. At the same time, partnerships with hospitals and clinical research institutions are helping to validate product performance and drive broader adoption across healthcare settings.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional
  • 2.2.2 Product type
  • 2.2.3 End use

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising incidences of gastrointestinal disorders, cancer, and other chronic conditions
    • 3.2.1.2 Increasing demand for minimally invasive procedures
    • 3.2.1.3 Technological advancements in disposable endoscopes
    • 3.2.1.4 Increased focus on contamination and infection control
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Lack of skilled physicians and endoscopists
  • 3.2.3 Market opportunities
    • 3.2.3.1 Regulatory push for infection control
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 RoW
• 3.5 Technology and innovation landscape
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Pricing analysis
• 3.7 Reimbursement scenario
• 3.8 Gap analysis
• 3.9 Porter's analysis
• 3.10 Pipeline analysis
• 3.11 PESTEL analysis
• 3.12 Gap analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
  • 4.3.1 By region
    • 4.3.1.1 North America
    • 4.3.1.2 Europe
    • 4.3.1.3 RoW
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn, Units)

• 5.1 Key trends
• 5.2 Bronchoscopes
• 5.3 Cystoscopes
• 5.4 Duodenoscopes
• 5.5 Hysteroscopes
• 5.6 Laryngoscopes
• 5.7 Ureteroscopes
• 5.8 Other product types

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Hospitals
• 6.3 Ambulatory surgical centers
• 6.4 Other end use

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn, Units)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 RoW

Chapter 8 Company Profiles

• 8.1 Ambu
• 8.2 Boston Scientific
• 8.3 CooperSurgical
• 8.4 Flexicare
• 8.5 Hoya Corporation
• 8.6 HugeMed
• 8.7 Karl Storz
• 8.8 OLYMPUS
• 8.9 Parburch MEDICAL
• 8.10 RICHARD WOLF